New Indications and Dosage Forms for 2012
See also: New Drug Approvals for 2012
January 3, 2012
- FDA Expands Use of Prevnar 13 Vaccine for People Ages 50 and Older
- CSL Behring Receives FDA Approval of Expanded Label on Berinert for Self-administration and Treatment of Acute Laryngeal Attacks of Hereditary Angioedema
January 13, 2012
January 19, 2012
January 24, 2012
January 25, 2012
- New FDA Approved Labeling For Vytorin (ezetimibe/simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
- UCB Announces FDA Approval for Keppra in Infants and Children from One Month of Age with Partial Onset Seizures
January 31, 2012
February 2, 2012
February 7, 2012
February 29, 2012
March 1, 2012
March 15, 2012
March 27, 2012
April 2, 2012
April 3, 2012
April 9, 2012
April 26, 2012
- Novartis drug Afinitor approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC
- FDA Approves Votrient for Advanced Soft Tissue Sarcoma
April 30, 2012
May 22, 2012
June 7, 2012
June 21, 2012
June 26, 2012
July 6, 2012
July 16, 2012
July 20, 2012
August 10, 2012
August 17, 2012
August 20, 2012
August 27, 2012
August 29, 2012
- FDA Approves Nucynta ER (tapentadol) Extended-Release Oral Tablets for the Management of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
- FDA Approves Afinitor Disperz - First Drug Formulated for Children with Rare Brain Tumor